Home Antibody All anti-CHUK antibodies
Anti-CHUK Antibody Y466
Also for CHUK (NM_001278)
|A synthetic peptide corresponding to residues near the C-term of human IKK-beta was used as immunogen.|
|Mouse, Human (Does not react with: Rat)
||Lot dependent; please refer to CoA along with shipment
|WB, IHC, FC
||WB: 1:1000 - 1:5000; IHC-P: Use at an assay dependent dilution; FC: 1:40; IP: 1:50
|Does not react with Rat. Is unsuitable for ICC/IF.|
|PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
|Is unsuitable for ICC/IF.
* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot - IKK beta antibody [Y466]; Anti-IKK beta antibody [Y466] at 1/5000 dilution + Daudi cell lysate.Observed band size : 87 kDa .
Western blot - IKK beta antibody [Y466]; .Exposure time : 3 minutes
Immunohistochemistry (Paraffin-embedded sections) - IKK beta antibody [Y466]; Immunohistochemical analysis of paraffin-embedded human cervical carcinoma using TA303451 at 1/100 dilution.
Flow Cytometry-Anti-IKK beta antibody [Y466](TA303451); Overlay histogram showing HeLa cells stained with TA303451 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody for 30 min at 22°C. The secondary antibody used was DyLight 488 goat anti-rabbit IgG (H+L) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1ug/1x10^6 cells) used under the same conditions. Acquisition of >5,000 events was performed.